Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Freedberg

Showing results (211-220 of 325) with videos related to

Pageof 33
Sort By:
Plos Medicine|January 19, 2012
What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysisAndrea L Ciaranello, Freddy Perez, Jo Keatinge, et al.
The American Journal of Medicine|March 5, 2005
Routine human immunodeficiency virus testing: an economic evaluation of current guidelinesRochelle P Walensky, Milton C Weinstein, April D Kimmel, et al.
Open Forum Infectious Diseases|July 17, 2015
Prenatal Transmission of Syphilis and Human Immunodeficiency Virus in Brazil: Achieving Regional Targets for EliminationRodrigo Cerda, Freddy Perez, Rosa Maria S M Domingues, et al.
Medical Care|October 26, 2006
The lifetime cost of current human immunodeficiency virus care in the United StatesBruce R Schackman, Kelly A Gebo, Rochelle P Walensky, et al.
Journal of the International AIDS Society|March 6, 2024
What does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic?Amir M Mohareb, Menan Gérard Kouamé, Marcellin Nouaman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 20, 2023
The Clinical Impact and Cost-Effectiveness of Clinic-Based Cognitive Behavioral Therapy for People With HIV, Depression, and Virologic Failure in South AfricaAditya R Gandhi, Emily P Hyle, Justine A Scott, et al.
Annals of Internal Medicine|May 31, 2016
The Anticipated Clinical and Economic Effects of 90-90-90 in South AfricaRochelle P Walensky, Ethan D Borre, Linda-Gail Bekker, et al.
Plos Medicine|November 22, 2017
The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysisLorna Dunning, Jordan A Francke, Divya Mallampati, et al.
Journal of the Pediatric Infectious Diseases Society|November 14, 2023
Projecting the Clinical and Economic Impacts of Changes to HIV Care Among Adolescents and Young Adults in the United States: Lessons From the COVID-19 PandemicIsaac Ravi Brenner, Kit N Simpson, Clare F Flanagan, et al.
Plos One|February 6, 2013
Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South AfricaPaul K Drain, Elena Losina, Gary Parker, et al.
Pageof 33

Showing results (211-220 of 325) with videos related to

Sort By:
Pageof 33
Plos Medicine|January 19, 2012
What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysisAndrea L Ciaranello, Freddy Perez, Jo Keatinge, et al.
The American Journal of Medicine|March 5, 2005
Routine human immunodeficiency virus testing: an economic evaluation of current guidelinesRochelle P Walensky, Milton C Weinstein, April D Kimmel, et al.
Open Forum Infectious Diseases|July 17, 2015
Prenatal Transmission of Syphilis and Human Immunodeficiency Virus in Brazil: Achieving Regional Targets for EliminationRodrigo Cerda, Freddy Perez, Rosa Maria S M Domingues, et al.
Medical Care|October 26, 2006
The lifetime cost of current human immunodeficiency virus care in the United StatesBruce R Schackman, Kelly A Gebo, Rochelle P Walensky, et al.
Journal of the International AIDS Society|March 6, 2024
What does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic?Amir M Mohareb, Menan Gérard Kouamé, Marcellin Nouaman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 20, 2023
The Clinical Impact and Cost-Effectiveness of Clinic-Based Cognitive Behavioral Therapy for People With HIV, Depression, and Virologic Failure in South AfricaAditya R Gandhi, Emily P Hyle, Justine A Scott, et al.
Annals of Internal Medicine|May 31, 2016
The Anticipated Clinical and Economic Effects of 90-90-90 in South AfricaRochelle P Walensky, Ethan D Borre, Linda-Gail Bekker, et al.
Plos Medicine|November 22, 2017
The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysisLorna Dunning, Jordan A Francke, Divya Mallampati, et al.
Journal of the Pediatric Infectious Diseases Society|November 14, 2023
Projecting the Clinical and Economic Impacts of Changes to HIV Care Among Adolescents and Young Adults in the United States: Lessons From the COVID-19 PandemicIsaac Ravi Brenner, Kit N Simpson, Clare F Flanagan, et al.
Plos One|February 6, 2013
Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South AfricaPaul K Drain, Elena Losina, Gary Parker, et al.
Pageof 33